Synergy CHC Draws Buy Rating from Ascendiant Capital with 303% Price Upside

Ascendiant Capital launched coverage of Synergy CHC (NASDAQ: SNYR) on February 2, 2026, initiating with a Buy recommendation that signals strong confidence in the company’s near-term prospects. The strategic recommendation comes alongside an ambitious analyst price target that suggests substantial room for growth in the equity.

According to data through January 14, 2026, Ascendiant’s research team projects an average one-year price target of $7.14 per share for the synergy-focused company. This valuation implies a 303.39% increase from the stock’s closing price of $1.77, with forecasts ranging from $7.07 to $7.35 across the analyst community. The projected annual non-GAAP earnings per share stand at 0.89, providing a quantitative foundation for the bullish thesis.

Analyst Targets Major Upside for Synergy Stock

The magnitude of the price target suggests that market participants expect significant operational and strategic improvements for Synergy CHC. The synergy company’s potential to capture value through cost optimization and revenue synergies appears central to the investment thesis. Market observers tracking SNYR note that the 303% upside potential places it among opportunities with the highest forecasted gains relative to current valuations.

The breadth of analyst coverage—with forecasts spanning from conservative to optimistic scenarios—reflects the range of interpretations about how effectively Synergy CHC can execute its business plan and capitalize on market opportunities. A concentration of bullish price targets suggests that most analysts expect the company to deliver on its promise to create shareholder value.

Institutional Investors Boost Stakes in SNYR

Fund sentiment has shifted notably in favor of the synergy opportunity, with 12 funds and institutions now maintaining positions in SNYR. This represents an increase of one new investor during the most recent quarter, a 9.09% expansion of the shareholder base. The average portfolio allocation to SNYR across all institutional investors stands at 0.05%, which has surged 442.50% as a proportion of total fund holdings.

Over the past three months, institutional ownership has accelerated significantly, with total shares held by institutional investors climbing 179.42% to reach 1,279,000 shares. This substantial accumulation reflects growing confidence among professional investors who have conducted deep due diligence on the synergy potential and long-term value creation prospects.

Major Shareholders and Recent Portfolio Moves

Gratia Capital emerges as the largest institutional stakeholder, owning 555,000 shares representing a 4.93% stake in the company. The firm’s recent filing reveals a dramatic entry or expansion, having increased its position by 100% from its prior holdings of zero shares. This signals a meaningful conviction in Synergy CHC’s investment case.

Heartland Advisors maintains a significant position with 550,000 shares, accounting for 4.89% ownership. Additional notable holders include Warberg Asset Management (34,000 shares, 0.30%), Geode Capital Management (28,000 shares, 0.25%), and Vanguard’s Total Stock Market Index Fund Investor Shares (22,000 shares, 0.20%).

Geode Capital Management has actively increased its commitment to SNYR, boosting its portfolio weight by 11.38% during the quarter, while also expanding its absolute share count by 62.84% from prior levels of 10,000 shares to current holdings of 28,000 shares. This represents deliberate portfolio repositioning in favor of the company.

What Fund Sentiment Reveals About Synergy

The convergence of analyst bullishness, expanding institutional ownership, and aggressive portfolio repositioning by established investment managers paints a coherent picture: professional investors and research teams have identified genuine value and growth potential in Synergy CHC. The buy recommendation from Ascendiant Capital validates this emerging consensus.

The data through mid-February 2026 suggests that investor appetite for the synergy story remains strong, with capital flowing into the position from multiple sources. Whether this optimistic outlook materializes will depend on the company’s ability to execute on the operational and strategic initiatives that underpin the bullish investment thesis.